Oncologica Case Study - Read Today

Oncologica, a leading pharmaceutical CRO, selects Arkivum to provide integrated long-term data management of their next-generation sequencing data

Oncologica, a leading pharmaceutical CRO, selects Arkivum to provide integrated long-term data management of their next-generation sequencing data

Oncologica, a leading precision oncology profiling company and Contract Research Organization (CRO) in the pharmaceutical industry, has chosen Arkivum Trust, to provide an integrated long-term data management solution. Arkivum will support Oncologica in managing its regulated genomics and patient data, generated by Thermo Fisher’s Ion GeneStudio S5 next-generation sequencing (NGS) system.

Oncologica develops precision oncology solutions to personalize cancer treatments. The CRO achieves this by identifying individual genetic biomarkers, which are used to match individual patient tumours to specific medicines. Oncologica uses the Ion GeneStudio S5 system to run tests and record genomic sequence data efficiently.

Testimonial

As a CRO, we need to demonstrate stringent data management and safeguarding practices to our existing and prospective clients in the pharmaceutical industry. Thanks to Arkivum and Thermo Fisher, we can focus our team on core pharmaceutical activities, knowing that the data is secure, usable, shareable, and compliant throughout its lifecycle. Arkivum provides our sponsoring organizations with the data they need, in neat, structured packages. This helps us demonstrate our value as a professional, long-term CRO partner

Marco Loddo, Co-Founder and Scientific Director at Oncologica

Ready to find out more?

Submit your details below for a personalised demo showing how your organisation could be benefitting from long-term data management today. Fields marked with an * are required. Need more information? See our blog or contact us.